IngredientesEl metilsulfonilmetano (MSM) es un compuesto organosulfurado de origen natural compuesto por azufre, carbono, hidrógeno y oxígeno, con la fórmula química (CH₃)₂SO₂. Se encuentra en pequeñas cantidades en algunas frutas, verduras, granos y productos animales, pero la mayoría del MSM suplementario se sintetiza a partir del dimetilsulfóxido (DMSO). El MSM es más conocido por sus funciones en la reducción de la inflamación, el apoyo a la salud articular y la mejora de la reparación tisular.
El MSM sirve como fuente biodisponible de azufre, un elemento esencial involucrado en la formación de colágeno, queratina y glutatión. Estos compuestos son cruciales para mantener una piel, cabello, uñas, articulaciones y vías de desintoxicación saludables. Al donar grupos de azufre, el MSM apoya la flexibilidad de la membrana celular, la actividad antioxidante y la integridad del tejido conectivo.
El MSM se usa ampliamente en la medicina natural y la nutrición deportiva para el manejo de la osteoartritis, el dolor muscular, la tendinitis y la inflamación inducida por el ejercicio. Los estudios clínicos muestran que la suplementación con MSM puede reducir significativamente el dolor y la rigidez articular, mejorar la función física y promover la recuperación después del ejercicio intenso. Sus efectos antiinflamatorios se atribuyen a la inhibición de citocinas proinflamatorias y a la modulación de las vías de señalización NF-κB.
De forma tópica, el MSM se usa en cremas y geles para aliviar el dolor muscular y articular, frecuentemente en combinación con otros agentes como árnica, mentol o glucosamina. Por vía oral, está disponible en cápsulas, polvos y fórmulas combinadas dirigidas a la movilidad, la salud de la piel y la desintoxicación.
Las aplicaciones adicionales incluyen el apoyo para las alergias, la modulación inmunitaria, la reparación intestinal y afecciones de la piel como la rosácea o el eccema, aunque la evidencia es más preliminar en estas áreas.
Uso Histórico
Si bien los alimentos y minerales ricos en azufre han sido utilizados durante mucho tiempo en la medicina tradicional para la salud de la piel y las articulaciones, el MSM en sí mismo es un compuesto relativamente moderno, derivado de la investigación sobre el DMSO, un solvente químico y agente antiinflamatorio estudiado extensamente a mediados del siglo XX.
En las décadas de 1950 y 1960, investigadores incluyendo al Dr. Stanley Jacob en la Universidad de Ciencias y Salud de Oregon exploraron las propiedades medicinales del DMSO y su metabolito menos volátil y más tolerable—el MSM. Se descubrió que el MSM conservaba muchos de los efectos antiinflamatorios y antioxidantes del DMSO sin el fuerte olor ni las características similares a las de un solvente, lo que llevó a su desarrollo como suplemento dietético.
Aunque no está reconocido como un nutriente esencial, el MSM ha ganado popularidad desde la década de 1990 como un compuesto natural de apoyo articular, frecuentemente utilizado junto con glucosamina y condroitina. Su papel en el metabolismo del azufre lo vincula a muchos remedios tradicionales basados en lodos ricos en azufre, aguas termales y hierbas, que se usaban para tratar la artritis, las enfermedades de la piel y la desintoxicación en diversas culturas.
Hoy en día, el MSM es un pilar de los enfoques integrativos para la salud articular y del tejido conectivo, valorado por su baja toxicidad, sus amplios beneficios antiinflamatorios y su papel de apoyo en la síntesis, reparación y regeneración del colágeno.
Condiciones de salud que aceite de hígado de bacalao puede ayudar a apoyar.
Omega-3 fatty acids reduce the inflammatory component of acne by suppressing leukotriene B4 and IL-1 production in skin. Vitamin A, related to the pharmaceutical acne treatment isotretinoin, regulates sebaceous gland activity. Small clinical studies support omega-3 supplementation reducing acne severity.
Vitamins A and D in cod liver oil have antioxidant properties. Vitamin A as retinol quenches singlet oxygen and free radicals; vitamin D regulates antioxidant enzyme expression. Omega-3s reduce oxidative stress indirectly by suppressing inflammatory ROS production. These mechanisms protect cells from oxidative damage.
EPA and DHA reduce neuroinflammation and support neurotransmitter balance implicated in anxiety. Observational data associate omega-3 status with lower anxiety prevalence. Controlled studies show omega-3 supplementation at ≥2 g/day reduces anxiety symptoms, particularly in stressed populations.
Marine oils including cod liver oil reduce inflammatory mediators implicated in arthritic joint pain and swelling. Multiple RCTs demonstrate clinically meaningful improvements in joint tenderness and stiffness. The EPA and DHA content are considered the primary active components.
DHA and EPA from cod liver oil have been studied in ADHD, with some trials showing modest symptom improvements. Low omega-3 status is consistently observed in children with ADHD. A noted review of cod liver oil in children's health reported CLO reduces risk of ADHD in children.
Cod liver oil modulates immune responses implicated in multiple autoimmune conditions via EPA and DHA's anti-inflammatory actions and vitamin D's immunoregulatory effects. Observational data link CLO use in infancy with lower type 1 diabetes risk. EPA and DHA are clinically studied in lupus, and vitamin D deficiency is associated with multiple sclerosis and other autoimmune disorders.
Cod liver oil's EPA and DHA reduce platelet aggregation and thrombus formation by competing with arachidonic acid for thromboxane A2 synthesis. Human studies document prolonged bleeding time with CLO supplementation. These antiplatelet effects contribute to cardiovascular protection.
Cod liver oil produces modest blood pressure reductions, particularly in hypertensive individuals. Clinical and observational data support a small but consistent antihypertensive effect. The 2016 AHRQ evidence review, however, found high-strength evidence of no significant blood pressure effect in supplemented subjects overall.
Cod liver oil provides vitamin D, which is essential for intestinal calcium absorption and bone mineralization. Studies show vitamin D supplementation from CLO supports bone mineral density maintenance and reduces fracture risk, particularly in older adults and those at risk for osteoporosis.
EPA and DHA from cod liver oil suppress matrix metalloproteinases (MMPs) and aggrecanases that degrade cartilage in inflammatory arthritis. Clinical studies in RA show reduced joint damage biomarkers with CLO supplementation. Omega-3s reduce IL-1β-driven chondrocyte apoptosis in vitro.
Cod liver oil's vitamin D has a well-documented scientific and historical role in preventing rickets—a childhood bone disease causing skeletal deformities. After vitamin D deficiency was identified as the cause of rickets in 1920, CLO became the standard prophylactic treatment for decades. Vitamin D supports calcium absorption for bone and tooth mineralization.
Cod liver oil's vitamins A and D regulate immune function in children. Observational data from Norway associate CLO use in the first year of life with lower risk of type 1 diabetes. Vitamin A reduces severity of childhood infections such as measles, and cod liver oil has been used for centuries to support immune resilience in children.
Cod liver oil modestly raises HDL cholesterol and has inconsistent effects on LDL and total cholesterol. A placebo-controlled RCT (600 patients) found CLO plus rosuvastatin lowered LDL and total cholesterol compared to statin alone. Fish oil meta-analyses show a small HDL increase but also a small LDL increase.
Cod liver oil reduces systemic markers of inflammation, particularly CRP. A prospective observational study of over 1,000 athletes found CLO users had 34% lower CRP responses compared to non-users. EPA and DHA inhibit pro-inflammatory cytokine production via the COX-2 and leukotriene pathways.
EPA and DHA reduce neuroinflammatory signaling that sensitizes pain pathways. In RA patients, cod liver oil significantly reduced pain intensity (67.5% reduction in one study). Omega-3 supplementation has broader evidence for reducing chronic pain across musculoskeletal and inflammatory pain conditions.
DHA is the predominant omega-3 in the brain and its concentration declines with aging. A 2022 review of 33 studies found omega-3 supplementation may protect against cognitive decline in healthy individuals without preexisting dementia. Evidence in established Alzheimer's disease is less consistent.
EPA and DHA in cod liver oil are associated with reduced depressive symptoms through anti-inflammatory and neurotransmitter-modulating mechanisms. Multiple observational studies and RCTs support omega-3 supplementation for depression, with EPA showing the strongest antidepressant signal. Evidence is particularly strong in elderly and high-inflammation populations.
Cod liver oil (5–13.56%) is recognized as a safe and effective OTC emollient and skin protectant for diaper rash by the FDA. StatPearls (NCBI Bookshelf) lists it among standard diaper dermatitis emollients. An RCT (Gozen et al., 2014, NICU population) evaluated a 40% zinc oxide with cod liver oil barrier cream formulation for neonatal diaper dermatitis.
Omega-3 fatty acids from cod liver oil reduce ocular surface inflammation implicated in dry eye disease. Multiple RCTs and meta-analyses have examined oral omega-3 supplementation for dry eye, with evidence of improvements in tear break-up time and ocular surface staining. However, a large recent trial (DREAM study) found no significant benefit over placebo.
Omega-3 fatty acids from cod liver oil maintain skin barrier function and hydration by being incorporated into epidermal phospholipids. Vitamin A supports skin cell turnover and barrier integrity. Both nutrients are associated with improved skin moisture and reduced transepidermal water loss.
Omega-3 fatty acids reduce the Th2-mediated inflammatory response underlying atopic eczema. Observational studies link higher maternal and infant omega-3 intake with lower eczema risk. Some RCTs show modest benefit of omega-3 supplementation for eczema severity, though evidence is not fully consistent.
DHA is concentrated in the prefrontal cortex, which governs attention and executive function. Low omega-3 status is associated with attention deficits in children. Supplementation studies show modest improvements in attention and learning in children with low omega-3 status, though effects in ADHD are inconsistent.
Vitamin A in cod liver oil is essential for rhodopsin synthesis in photoreceptors, maintaining visual function. DHA is a major structural component of the retina. Both nutrients support overall eye health, with clinical evidence linking adequate intake to preservation of visual acuity and reduced risk of inflammatory eye conditions.
Cod liver oil addresses multiple age-related processes: it reduces systemic inflammation (inflammaging), supports bone density, slows cognitive decline, protects retinal health, and provides antioxidant support via vitamins A and D. Population-level observational data link long-term omega-3 and vitamin D adequacy with healthy aging outcomes.
DHA from cod liver oil is essential for fetal and infant brain and retinal development. Vitamin A supports cellular differentiation and tissue growth. Vitamin D promotes skeletal development and immune maturation. Together these nutrients support the full spectrum of healthy growth in infants and children.
Cod liver oil contributes to cardiovascular health primarily through triglyceride reduction, modest HDL elevation, and anti-inflammatory and antithrombotic effects. A large interventional study (870 patients) found fewer myocardial infarction events with CLO supplementation. Evidence for broad cardiovascular event reduction is more mixed.
EPA and DHA in cod liver oil improve insulin sensitivity through reduced inflammation and altered adipocyte lipid metabolism. A double-blind RCT in gestational diabetes patients found CLO significantly reduced HOMA-IR and fasting glucose compared to placebo. Omega-3s have been shown to improve insulin resistance in obese and non-obese patients with an inflammatory phenotype.
DHA is highly concentrated in retinal photoreceptors and observational studies consistently associate higher omega-3 intake with lower risk of age-related macular degeneration. However, the large AREDS2 RCT did not find that omega-3 supplementation significantly slowed AMD progression.
DHA is essential for hippocampal neuronal membrane function, synaptic plasticity, and memory consolidation. Supplementation studies show modest memory benefits, particularly in early-stage cognitive decline. Evidence in established dementia is less consistent.
Omega-3 fatty acids from cod liver oil address multiple metabolic syndrome components: triglycerides, blood pressure, insulin resistance, and inflammation. A meta-analysis of 8 RCTs found omega-3 supplementation significantly reduced triglycerides and systolic and diastolic blood pressure in metabolic syndrome patients.
Vitamin A is the biochemical precursor to retinal, the visual pigment in rod photoreceptors responsible for low-light vision. Cod liver oil is a dense source of preformed vitamin A. Deficiency causes night blindness, and supplementation with vitamin A-rich foods like CLO corrects this deficiency.
Cod liver oil's vitamin D supports intestinal calcium absorption and bone mineralization, directly opposing the mechanisms of osteoporosis. Clinical data show vitamin D supplementation increases bone mineral density at the lumbar spine and femoral neck, reducing fracture risk. CLO has been used as an osteoporosis prevention strategy since the 20th century.
Cod liver oil's vitamins A and D support immune reconstitution and tissue repair during recovery from illness. DHA and EPA reduce post-infective inflammation. Evidence from COVID-19 and general upper respiratory infection contexts suggests cod liver oil users have improved recovery trajectories.
DHA from cod liver oil supports fetal brain and retinal development; vitamin D supports fetal bone mineralization. CLO use during pregnancy has been associated with reduced perinatal complications in gestational diabetes. Evidence from a Norwegian study links prenatal CLO use with lower type 1 diabetes risk in offspring.
Fish oil supplementation including cod liver oil has shown beneficial effects in psoriasis in some clinical studies. EPA competitively inhibits arachidonic acid-derived leukotriene B4, a key inflammatory mediator in psoriatic plaques. Omega-3 and vitamin D combinations show promise in reducing plaque severity.
Cod liver oil's EPA and DHA suppress the inflammatory mediators that drive rheumatoid arthritis. Clinical trials have shown reductions in morning stiffness, swollen and painful joints, and NSAID requirements. A double-blind RCT found 39% of RA patients could reduce daily NSAID use by >30% with cod liver oil supplementation.
Cod liver oil addresses two converging drivers of seasonal mood decline: vitamin D deficiency (which peaks in winter) and omega-3 insufficiency. Large observational studies link CLO use with lower rates of depression in populations with limited winter sunlight. Seasonal affective disorder involves both nutrient deficiencies.
Omega-3 fatty acids maintain skin elasticity and hydration by being incorporated into epidermal lipid membranes and reducing inflammatory collagen degradation. Vitamin A in cod liver oil (as retinol) is structurally related to clinically proven anti-aging retinoids, supporting cell turnover and collagen synthesis.
Cod liver oil reliably lowers serum triglycerides, the most robust and consistent lipid effect documented for marine oils. The mechanism involves reduced hepatic VLDL synthesis. Studies show reductions of 15–30% at typical therapeutic doses.
Cod liver oil's vitamin D reduces susceptibility to respiratory tract infections by supporting innate and adaptive mucosal immunity. An observational study (HUNT study, Norway) found regular cod liver oil intake was associated with lower incidence of adult asthma. CLO's anti-inflammatory properties also modulate airway inflammation.
Topical and oral cod liver oil supports wound healing through multiple mechanisms. Vitamin A promotes epithelial cell proliferation; vitamin D supports immune response and tissue repair; omega-3s reduce excessive wound inflammation. An experimental study found topical CLO ointment accelerated wound healing in an animal model.
Sistemas corporales que aceite de hígado de bacalao puede ayudar a apoyar.
Volver